KYNTRA BIO, INC.: prepaid expenses and other current assets

What this measure means

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Exact concept: us-gaap:PrepaidExpenseAndOtherAssetsCurrent. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.

Coverage of this history

Selected reporting periods run from 2014-12-31 to 2025-12-31. The SEC response was captured on 2026-09-20.

Selected filing history

Related financial histories

• KYNTRA BIO, INC.: total assets
• KYNTRA BIO, INC.: total liabilities
• KYNTRA BIO, INC.: stockholders equity
• KYNTRA BIO, INC.: cash and cash equivalents
• KYNTRA BIO, INC.: net income or loss
• KYNTRA BIO, INC.: operating cash flow
• KYNTRA BIO, INC.: capital expenditure payments
• KYNTRA BIO, INC.: revenue
• KYNTRA BIO, INC.: contract revenue excluding tax
• KYNTRA BIO, INC.: financing cash flow
• KYNTRA BIO, INC.: investing cash flow
• KYNTRA BIO, INC.: retained earnings or deficit
• KYNTRA BIO, INC.: basic weighted-average shares
• KYNTRA BIO, INC.: diluted weighted-average shares
• KYNTRA BIO, INC.: basic earnings per share
• KYNTRA BIO, INC.: diluted earnings per share
• KYNTRA BIO, INC.: income tax expense or benefit
• KYNTRA BIO, INC.: net property, plant and equipment
• KYNTRA BIO, INC.: share-based compensation expense
• KYNTRA BIO, INC.: operating income or loss
• KYNTRA BIO, INC.: current assets
• KYNTRA BIO, INC.: interest expense
• KYNTRA BIO, INC.: current liabilities
• KYNTRA BIO, INC.: current accounts payable
• KYNTRA BIO, INC.: net current accounts receivable
• KYNTRA BIO, INC.: operating expenses
• KYNTRA BIO, INC.: net inventory
• KYNTRA BIO, INC.: cost of revenue
• KYNTRA BIO, INC.: selling, general and administrative expense
• KYNTRA BIO, INC.: research and development expense
• KYNTRA BIO, INC.: common shares outstanding
• KYNTRA BIO, INC.: additional paid-in capital
• KYNTRA BIO, INC.: accumulated other comprehensive income or loss
• KYNTRA BIO, INC.: total equity including noncontrolling interests
• KYNTRA BIO, INC.: operating lease right-of-use asset
• KYNTRA BIO, INC.: operating lease liability
• KYNTRA BIO, INC.: gross property, plant and equipment
• KYNTRA BIO, INC.: accumulated depreciation on property, plant and equipment
• KYNTRA BIO, INC.: other noncurrent assets
• KYNTRA BIO, INC.: other noncurrent liabilities
• KYNTRA BIO, INC.: accrued current liabilities
• KYNTRA BIO, INC.: current contract liabilities
• KYNTRA BIO, INC.: net deferred tax assets
• KYNTRA BIO, INC.: pre-tax income or loss from continuing operations
• KYNTRA BIO, INC.: profit or loss including noncontrolling interests
• KYNTRA BIO, INC.: comprehensive income or loss
• KYNTRA BIO, INC.: general and administrative expense
• KYNTRA BIO, INC.: depreciation expense
• KYNTRA BIO, INC.: nonoperating income or expense
• KYNTRA BIO, INC.: current income tax expense or benefit
• KYNTRA BIO, INC.: deferred income tax expense or benefit
• KYNTRA BIO, INC.: interest paid, net
• KYNTRA BIO, INC.: proceeds from issuing common stock
• KYNTRA BIO, INC.: operating lease payments
• KYNTRA BIO, INC.: change in accounts receivable
• KYNTRA BIO, INC.: change in inventories
• KYNTRA BIO, INC.: change in accounts payable

Inspect the source

Entity

KYNTRA BIO, INC. / CIK 0000921299

Captured

2026-09-20T05:08:01.696Z

SEC response SHA-256

60313741a614d381e73fc033725566bd06ee27593e71b4e95a10100fd7a817db

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

• Get an API key and run your first validation
• Connect the MCP server to your coding assistant
• Inspect the ALPHAC engine on GitHub
• Read the MCP server source and integration examples

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000921299.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))